SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Hansson Mona) srt2:(2020-2024)"

Sökning: WFRF:(Hansson Mona) > (2020-2024)

  • Resultat 1-4 av 4
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  • Hansson, Karin, et al. (författare)
  • Tick-borne encephalitis (TBE) vaccine failures : A ten-year retrospective study supporting the rationale for adding an extra priming dose in individuals from the age of 50 years
  • 2020
  • Ingår i: Clinical Infectious Diseases. - : Oxford University Press. - 1058-4838 .- 1537-6591. ; 70:2, s. 245-251
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Southern Sweden is endemic for tick borne encephalitis (TBE), with Stockholm County as one of the high-risk areas. The aim of this study was to describe cases of vaccine failures, and to optimize future vaccination recommendations.METHODS: Patients with TBE were identified in the notification database at the Department of Communicable Disease Control and Prevention in the county of Stockholm during 2006-2015. Vaccine failure was defined as TBE despite adherence to the recommended vaccination schedule with at least two doses. Clinical data were extracted from medical records.RESULTS: A total of 1004 TBE cases were identified, 53 (5%) were defined as vaccine failures. In this latter group the median age was 62 years (6-83). Forty-three (81%) patients were over 50 years of age and two were children. Approximately half of the patients had comorbidities with diseases affecting the immune system accounting for 26% of all cases.Vaccine failures following the third or fourth vaccine dose accounted for 36 (68%) of the patients. Severe and moderate TBE disease affected 81% of the cases.CONCLUSION: To our knowledge, this is the largest documented cohort of TBE-vaccine failures. Vaccine failure after five TBE-vaccine doses is rare. Our data provides rationale for adding an extra priming dose to the age group 50 years and older.
  •  
4.
  • Partanen, Anu, et al. (författare)
  • Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group
  • 2024
  • Ingår i: Cancers. - : MDPI. - 2072-6694. ; 16:5
  • Tidskriftsartikel (refereegranskat)abstract
    • Scarce data exist on double maintenance in transplant-eligible high-risk (HR) newly diagnosed multiple myeloma (NDMM) patients. This prospective phase 2 study enrolled 120 transplant-eligible NDMM patients. The treatment consisted of four cycles of ixazomib-lenalidomide-dexamethasone (IRD) induction plus autologous stem cell transplantation followed by IRD consolidation and cytogenetic risk-based maintenance therapy with lenalidomide + ixazomib (IR) for HR patients and lenalidomide (R) alone for NHR patients. The main endpoint of the study was undetectable minimal residual disease (MRD) with sensitivity of <10-5 by flow cytometry at any time, and other endpoints were progression-free survival (PFS) and overall survival (OS). We present the preplanned analysis after the last patient has been two years on maintenance. At any time during protocol treatment, 28% (34/120) had MRD < 10-5 at least once. At two years on maintenance, 66% of the patients in the HR group and 76% in the NHR group were progression-free (p = 0.395) and 36% (43/120) were CR or better, of which 42% (18/43) had undetectable flow MRD <10-5. Altogether 95% of the patients with sustained MRD <10-5, 82% of the patients who turned MRD-positive, and 61% of those with positive MRD had no disease progression at two years on maintenance (p < 0.001). To conclude, prolonged maintenance with all-oral ixazomib plus lenalidomide might improve PFS in HR patients.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-4 av 4
Typ av publikation
tidskriftsartikel (3)
bokkapitel (1)
Typ av innehåll
refereegranskat (3)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Lindquist, Lars (1)
Abelsson, Johanna (1)
Anttila, Pekka (1)
Waage, Anders (1)
Hansson, Markus (1)
Carlson, Kristina (1)
visa fler...
Ahlstrand, Erik (1)
Hansson, Lars (1)
Eklund, Mona (1)
Lilja, Mona, 1971- (1)
Vene, Sirkka (1)
Axelsson, Per (1)
Burman, Anders, 1977 (1)
Nahi, Hareth (1)
Bengtsson Tops, Anit ... (1)
Hansson, Karin (1)
Insulander, Mona (1)
Bejerholm, Ulrika (1)
Askling, Helena H. (1)
Markström, Urban (1)
Rosdahl, Anja, 1972- (1)
Brunt, David, 1949- (1)
Brunt, David (1)
Baaz, Mikael, 1966 (1)
Hansson, Stina, 1974 (1)
Strandberg Hassellin ... (1)
Hellberg, Sofie, 197 ... (1)
Herath, Dhammika, 19 ... (1)
Schulz, Michael, 196 ... (1)
Sentama, Ezechiel, 1 ... (1)
Sirik, Savina (1)
Wiksell, Kristin (1)
Gredmark-Russ, Sara (1)
Schjesvold, Fredrik (1)
Peceliunas, Valdas (1)
Klimkowska, Monika (1)
Lauri, Birgitta (1)
Silvennoinen, Raija (1)
Uttervall, Katarina (1)
Haukas, Einar (1)
Svensson, Ronald (1)
Szatkowski, Damian (1)
Partanen, Anu (1)
Saeily, Marjaana (1)
Putkonen, Mervi (1)
Sankelo, Marja (1)
Marttila, Anu (1)
Mikkola, Maija (1)
Karlsson, Conny (1)
Sikioe, Anu (1)
visa färre...
Lärosäte
Karolinska Institutet (2)
Göteborgs universitet (1)
Örebro universitet (1)
Linköpings universitet (1)
Lunds universitet (1)
Linnéuniversitetet (1)
Språk
Engelska (3)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (3)
Samhällsvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy